JBM (Healthcare) Limited (HKG:2161)
Hong Kong · Delayed Price · Currency is HKD 2.800
+0.090 (3.32%)
Mar 10, 2026, 3:57 PM HKT
JBM (Healthcare) Market Cap
JBM (Healthcare) has a market cap or net worth of 2.21 billion as of March 10, 2026. Its market cap has increased by 52.86% in one year.
Market Cap
2.21B
Enterprise Value
2.41B
Revenue
812.98M
Ranking
n/a
PE Ratio
11.01
Stock Price
2.80
Market Cap Chart
Since February 5, 2021, JBM (Healthcare)'s market cap has increased from 1.93B to 2.21B, an increase of 14.74%. That is a compound annual growth rate of 2.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 2.21B | 1.88% |
| Dec 31, 2025 | 2.17B | 40.57% |
| Dec 31, 2024 | 1.55B | 71.27% |
| Dec 29, 2023 | 903.02M | 6.82% |
| Dec 30, 2022 | 845.38M | -8.16% |
| Dec 31, 2021 | 920.50M | -52.31% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edding Genor Group Holdings | 5.34B |
| VISEN Pharmaceuticals | 3.37B |
| Hua Medicine (Shanghai) | 3.10B |
| Jacobson Pharma Corporation | 2.56B |
| Essex Bio-Technology | 2.29B |
| Golden Throat Holdings Group Company | 2.27B |
| Dawnrays Pharmaceutical (Holdings) | 1.74B |
| Chia Tai Enterprises International | 1.39B |